When Cancer Spreads Inside the Abdomen: What Treatment Looks Like

Hearing that cancer has spread to the lining inside the abdomen, often called peritoneal surface malignancy or peritoneal metastasis, is difficult news. It is natural to wonder what it means for treatment, and whether surgery is still possible.

This is not one specific cancer. It describes cancer that has reached the peritoneum, the thin tissue lining the abdominal cavity, usually spreading there from a cancer that started elsewhere, such as the ovary, appendix, colon, rectum or stomach. In carefully selected patients, specialised treatment can still be considered.

What Exactly Is Peritoneal Surface Malignancy?

The peritoneum is a smooth membrane lining the abdomen and covering many of its organs. When cancer cells reach this surface and form tumour deposits, doctors describe it as peritoneal surface malignancy, a pattern of spread rather than a cancer that starts in the peritoneum itself.

The amount of disease varies widely. Some patients have only a handful of small deposits, while others have involvement across several areas of the abdomen, which is why assessment has to be individual rather than based on the diagnosis alone.

Which Cancers Can Reach the Peritoneum?

Several cancers can spread this way, each behaving differently once they do:

• Ovarian cancer
• Colorectal cancer
• Appendiceal cancer
• Stomach or gastric cancer
• Certain cancers of the small intestine
• Other abdominal and pelvic cancers

Some produce numerous small deposits, others form larger masses or significant abdominal fluid, so the original cancer and its biology shape the whole treatment plan.

Signs Worth Getting Checked

Some patients have few symptoms, particularly when the spread is found during scans or follow-up for another cancer. When symptoms do appear, they can include:

• Persistent abdominal bloating or swelling
• Abdominal or pelvic discomfort
• Feeling full sooner than usual while eating
• Reduced appetite or unexplained weight loss
• Nausea or vomiting
• Changes in bowel habits, or constipation
• Increasing abdominal size from fluid build-up

None of these are specific to peritoneal disease on their own, but persistent symptoms, especially with a known history of cancer, are worth having evaluated rather than dismissed.

How Is It Diagnosed?

Diagnosis brings together several pieces of information: the original cancer, previous treatment, symptoms, examination and imaging, typically starting with a CT scan and sometimes followed by MRI, PET-CT, blood tests, tumour markers, or a biopsy. 

The aim goes beyond confirming spread. Doctors also need to understand how much disease is present, where it sits, which structures are involved, whether visible disease could potentially be removed, and whether major surgery would be safe for that patient.

Can It Be Removed With Surgery? CRS and HIPEC Explained

Peritoneal metastasis is often an advanced disease, but that does not mean every patient has the same options. Some have diseases that can be surgically removed or significantly reduced; others are better served by systemic treatment. The decision depends on cancer type, the amount and spread of tumour, organ involvement, prior treatment response and general health.

Cytoreductive surgery (CRS)

CRS is a specialised operation to remove visible tumour deposits from the abdomen, sometimes including affected portions of the peritoneum or nearby organs. It is complex and not suitable for everyone, and one of its central goals is achieving complete or near-complete removal of visible disease wherever it can be done safely.

HIPEC

Hyperthermic Intraperitoneal Chemotherapy, or HIPEC, delivers heated chemotherapy directly into the abdominal cavity after CRS, targeting microscopic cancer cells that may remain once visible disease is removed. 

CRS is the surgical step; HIPEC is the chemotherapy step, and while they are often performed together, not every patient who has surgery will need HIPEC.

Who May Be Considered for CRS and HIPEC?

This is only decided after detailed evaluation, weighing:

• Type of cancer and how it tends to behave
• Extent of peritoneal disease and its location
• Whether the visible tumour can realistically be removed
• Previous chemotherapy or surgery
• General health and ability to tolerate major surgery
• Overall treatment goals, balancing benefit against risk

There is no single scan result or age cut-off that decides eligibility on its own.

What Does Recovery Involve?

Recovery from CRS and HIPEC differs from a routine abdominal operation. Because surgery can be extensive, patients often need several days or longer in hospital while the team monitors pain, nutrition, bowel function and fluid balance. Some points to expect:

• Walking may begin relatively soon after surgery, when considered safe
• Eating normally can take time, and nutritional support may be needed
• Energy levels often stay lower than usual for some time after discharge
• Follow-up appointments are an important part of ongoing recovery

How long recovery takes depends on the extent of surgery, the patient's general health, and whether complications occur.

Taking the Next Step

Peritoneal spread does not mean the same thing for every patient, and treatment decisions depend on the original cancer, extent of disease, prior treatment and overall health. Dr Snita Sinukumar provides surgical oncology care in Pune with a focus on complex cancers, including peritoneal surface malignancy and advanced ovarian cancer, with CRS and HIPEC considered for appropriate patients after detailed evaluation.

If you or a loved one has received this diagnosis, book a consultation to review the diagnosis, scans and treatment history together.

FAQs